Skip to main content
Quest Diagnostics

Gene-Specific Variant Interpretation Guidelines in GCK, HNF1A, and HNF4A: Update From the ClinGen Monogenic Diabetes Expert Panel

ACMG 2020: Annual Clinical Genetics Meeting
Virtual [in-person conference canceled], March 17-21, 2020

Gene-specific Variant Interpretation Guidelines in GCK, HNF1A, and HNF4A: Update from the ClinGen Monogenic Diabetes Expert Panel

Authors: Zhang H, Maloney KA, Skopkova M, Saint-Martin C, Saliganan S, Cano OD, Cosentino R, Letourneau L, Murphy R, Kettunen J, Parikh H, Gasperikova D, Urano F, Richard G, Molnes J , Maston G, Bellanné-Chantelot C, Colclough K, Pollin TI

Specialties: genetics, endocrinology, cardiology, cardiovascular disease

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.